Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging

BACKGROUND: Oral deferiprone was suggested to be more effective than subcutaneous desferrioxamine for removing heart iron. Oral once-daily chelator deferasirox has recently been made commercially available but its long-term efficacy on cardiac iron and function has not yet been established. Our stud...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Pepe, Alessia, Meloni, Antonella, Capra, Marcello, Cianciulli, Paolo, Prossomariti, Luciano, Malaventura, Cristina, Putti, Maria Caterina, Lippi, Alma, Romeo, Maria Antonietta, Bisconte, Maria Grazia, Filosa, Aldo, Caruso, Vincenzo, Quarta, Antonella, Pitrolo, Lorella, Missere, Massimiliano, Midiri, Massimo, Rossi, Giuseppe, Positano, Vincenzo, Lombardi, Massimo, Maggio, Aurelio
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2011
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3012763/
https://ncbi.nlm.nih.gov/pubmed/20884710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.019042
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares